EGFR and neoplasm: Combined with a BiTE specific for the wild-type EGFR, which is frequently overexpressed in glioblastoma, BiTE co-expression has the potential to recruit bystander cells and redirect them against wild type EGFR, thus resulting in complete tumour control.